Literature DB >> 23796933

Daptomycin In Vitro Activity against Methicillin-Resistant Staphylococcus aureus Is Enhanced by d-Cycloserine in a Mechanism Associated with a Decrease in Cell Surface Charge.

O Gasch1,2,3, S K Pillai4,2, J Dakos4, S Miyakis4,2,5, R C Moellering4,2, G M Eliopoulos4,2.   

Abstract

The killing activity of daptomycin against an isogenic pair of daptomycin-susceptible and daptomycin-nonsusceptible (DNS) methicillin-resistant Staphylococcus aureus (MRSA) strains was enhanced by the addition of certain cell wall agents at 1× MIC. However, when high inocula of the DNS strain were used, no significant killing was observed in our experiments. Cytochrome c binding assays revealed d-cycloserine as the only agent associated with a reduction in the cell surface charge for both strains at the concentrations used.
Copyright © 2013, American Society for Microbiology. All Rights Reserved.

Entities:  

Year:  2013        PMID： 23796933      PMCID： PMC3754330          DOI： 10.1128/AAC.00799-13

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  17 in total

1.  THE ENZYMATIC SYNTHESIS OF D-ALANYL-D-ALANINE. 3. ON THE INHIBITION OF D-ALANYL-D-ALANINE SYNTHETASE BY THE ANTIBIOTIC D-CYCLOSERINE.

Authors:  F C NEUHAUS; J L LYNCH
Journal:  Biochemistry       Date:  1964-04       Impact factor: 3.162

2.  Evaluation of in vitro interaction of daptomycin with gentamicin or beta-lactam antibiotics against Staphylococcus aureus and Enterococci by FIC index and timed-kill curves.

Authors:  D R Snydman; L A McDermott; N V Jacobus
Journal:  J Chemother       Date:  2005-12       Impact factor: 1.714

3.  Functional relationship between bacterial cell density and the efficacy of antibiotics.

Authors:  Klas I Udekwu; Nicholas Parrish; Peter Ankomah; Fernando Baquero; Bruce R Levin
Journal:  J Antimicrob Chemother       Date:  2009-02-13       Impact factor: 5.790

4.  Use of antistaphylococcal beta-lactams to increase daptomycin activity in eradicating persistent bacteremia due to methicillin-resistant Staphylococcus aureus: role of enhanced daptomycin binding.

Authors:  Abhay Dhand; Arnold S Bayer; Joseph Pogliano; Soo-Jin Yang; Michael Bolaris; Victor Nizet; Guiquing Wang; George Sakoulas
Journal:  Clin Infect Dis       Date:  2011-07-15       Impact factor: 9.079

5.  Emergence of a clinical daptomycin-resistant Staphylococcus aureus isolate during treatment of methicillin-resistant Staphylococcus aureus bacteremia and osteomyelitis.

Authors:  Francisco M Marty; Wendy W Yeh; Christine B Wennersten; Lata Venkataraman; Esperanza Albano; Edwin P Alyea; Howard S Gold; Lindsey R Baden; Satish K Pillai
Journal:  J Clin Microbiol       Date:  2006-02       Impact factor: 5.948

6.  Impact of high-inoculum Staphylococcus aureus on the activities of nafcillin, vancomycin, linezolid, and daptomycin, alone and in combination with gentamicin, in an in vitro pharmacodynamic model.

Authors:  Kerry L LaPlante; Michael J Rybak
Journal:  Antimicrob Agents Chemother       Date:  2004-12       Impact factor: 5.191

7.  Mechanism of D-cycloserine action: alanine racemase from Escherichia coli W.

Authors:  M P Lambert; F C Neuhaus
Journal:  J Bacteriol       Date:  1972-06       Impact factor: 3.490

8.  Sequence of the putative alanine racemase operon in Staphylococcus aureus: insertional interruption of this operon reduces D-alanine substitution of lipoteichoic acid and autolysis.

Authors:  I Kullik; R Jenni; B Berger-Bächi
Journal:  Gene       Date:  1998-09-28       Impact factor: 3.688

9.  Analysis of cell membrane characteristics of in vitro-selected daptomycin-resistant strains of methicillin-resistant Staphylococcus aureus.

Authors:  Nagendra N Mishra; Soo-Jin Yang; Ayumi Sawa; Aileen Rubio; Cynthia C Nast; Michael R Yeaman; Arnold S Bayer
Journal:  Antimicrob Agents Chemother       Date:  2009-03-30       Impact factor: 5.191

10.  The GraRS regulatory system controls Staphylococcus aureus susceptibility to antimicrobial host defenses.

Authors:  Dirk Kraus; Silvia Herbert; Sascha A Kristian; Arya Khosravi; Victor Nizet; Friedrich Götz; Andreas Peschel
Journal:  BMC Microbiol       Date:  2008-06-02       Impact factor: 3.605
View more
  7 in total

1.  Heterogeneity of genetic pathways toward daptomycin nonsusceptibility in Staphylococcus aureus determined by adjunctive antibiotics.

Authors:  Andrew D Berti; Sarah L Baines; Benjamin P Howden; George Sakoulas; Victor Nizet; Richard A Proctor; Warren E Rose
Journal:  Antimicrob Agents Chemother       Date:  2015-03-02       Impact factor: 5.191

2.  D-cycloserine increases the effectiveness of vancomycin against vancomycin-highly resistant Staphylococcus aureus.

Authors:  Fumiaki Tabuchi; Yasuhiko Matsumoto; Masaki Ishii; Keita Tatsuno; Mitsuhiro Okazaki; Tomoaki Sato; Kyoji Moriya; Kazuhisa Sekimizu
Journal:  J Antibiot (Tokyo)       Date:  2017-06-07       Impact factor: 2.649

3.  The Combination of Daptomycin and Fosfomycin Has Synergistic, Potent, and Rapid Bactericidal Activity against Methicillin-Resistant Staphylococcus aureus in a Rabbit Model of Experimental Endocarditis.

Authors:  Cristina García-de-la-Mària; Oriol Gasch; Javier García-Gonzalez; Dolors Soy; Evelyn Shaw; Juan Ambrosioni; Manel Almela; Juan M Pericàs; Adrián Tellez; Carlos Falces; Marta Hernandez-Meneses; Elena Sandoval; Eduard Quintana; Barbara Vidal; Jose M Tolosana; David Fuster; Jaume Llopis; Miquel Pujol; Asuncion Moreno; Francesc Marco; Jose M Miró
Journal:  Antimicrob Agents Chemother       Date:  2018-05-25       Impact factor: 5.191

4.  Glucose Augments Killing Efficiency of Daptomycin Challenged Staphylococcus aureus Persisters.

Authors:  Marcel Prax; Lukas Mechler; Christopher Weidenmaier; Ralph Bertram
Journal:  PLoS One       Date:  2016-03-09       Impact factor: 3.240

5.  Daptomycin Plus Fosfomycin Versus Daptomycin Alone for Methicillin-resistant Staphylococcus aureus Bacteremia and Endocarditis: A Randomized Clinical Trial.

Authors:  Miquel Pujol; José-María Miró; Evelyn Shaw; Jose-María Aguado; Rafael San-Juan; Mireia Puig-Asensio; Carles Pigrau; Esther Calbo; Miguel Montejo; Regino Rodriguez-Álvarez; María-Jose Garcia-Pais; Vicente Pintado; Rosa Escudero-Sánchez; Joaquín Lopez-Contreras; Laura Morata; Milagros Montero; Marta Andrés; Juan Pasquau; María-Del-Mar Arenas; Belén Padilla; Javier Murillas; Alfredo Jover-Sáenz; Luis-Eduardo López-Cortes; Graciano García-Pardo; Oriol Gasch; Sebastian Videla; Pilar Hereu; Cristian Tebé; Natalia Pallarès; Mireia Sanllorente; María-Ángeles Domínguez; Jordi Càmara; Anna Ferrer; Ariadna Padullés; Guillermo Cuervo; Jordi Carratalà
Journal:  Clin Infect Dis       Date:  2021-05-04       Impact factor: 9.079

6.  Proteome profiling of evolved methicillin-resistant Staphylococcus aureus strains with distinct daptomycin tolerance and resistance phenotypes.

Authors:  Jordy Evan Sulaiman; Lexin Long; Pei-Yuan Qian; Henry Lam
Journal:  Front Microbiol       Date:  2022-08-04       Impact factor: 6.064

7.  Daptomycin Resistant Staphylococcus aureus Clinical Strain With Novel Non-synonymous Mutations in the mprF and vraS Genes: A New Insight Into Daptomycin Resistance.

Authors:  Artur J Sabat; Marco Tinelli; Hajo Grundmann; Viktoria Akkerboom; Monica Monaco; Maria Del Grosso; Giulia Errico; Annalisa Pantosti; Alexander W Friedrich
Journal:  Front Microbiol       Date:  2018-11-06       Impact factor: 5.640
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.